0001601485-22-000013.txt : 20220304
0001601485-22-000013.hdr.sgml : 20220304
20220304162153
ACCESSION NUMBER: 0001601485-22-000013
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220302
FILED AS OF DATE: 20220304
DATE AS OF CHANGE: 20220304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Neylan John F.
CENTRAL INDEX KEY: 0001640447
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39990
FILM NUMBER: 22714352
MAIL ADDRESS:
STREET 1: 750 LEXINGTON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Angion Biomedica Corp.
CENTRAL INDEX KEY: 0001601485
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113430072
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 51 CHARLES LINDBERGH BOULEVARD
CITY: UNIONDALE
STATE: NY
ZIP: 11553
BUSINESS PHONE: (415) 655-4899
MAIL ADDRESS:
STREET 1: 51 CHARLES LINDBERGH BOULEVARD
CITY: UNIONDALE
STATE: NY
ZIP: 11553
4
1
wf-form4_164642889806390.xml
FORM 4
X0306
4
2022-03-02
0
0001601485
Angion Biomedica Corp.
ANGN
0001640447
Neylan John F.
C/O ANGION BIOMEDICA CORP.
51 CHARLES LINDBERGH BLVD.
UNIONDALE
NY
11553
0
1
0
0
See Remarks
Stock Option (Right to Buy)
1.99
2022-03-02
4
A
0
175000
0
A
2032-03-01
Common Stock
175000.0
175000
D
Stock Option (Right to Buy)
1.99
2022-03-02
4
A
0
100000
0
A
2032-03-01
Common Stock
100000.0
275000
D
The total number of options vest in forty-eight (48) successive and equal monthly installments as measured from March 3, 2022 (the "Vesting Commencement Date"), such that 100% of the options will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
The total number of options vest in equal parts on July 31, 2022 and December 31, 2022, such that 100% of the options will be fully vested and exercisable on December 31, 2022.
Executive Vice President, Chief Medical Officer and Head of Research
/s/ Jennifer J. Rhodes, as attorney-in fact for John F. Neylan
2022-03-04